Nearly 120 million Nova Consumer shares will be traded on UPCoM
Báo Thanh niên•04/11/2023
The Hanoi Stock Exchange has just announced that nearly 120 million shares with code NCG of Nova Consumer Group will be traded on UPCoM on November 9.
The reference price on the first trading day of NCG code of Nova Consumer Group Corporation is 38,000 VND, fluctuation range +/- 40%. At this reference price, the company's capitalization value is about 4,550 billion VND, equivalent to 190 million USD.
Nova Consumer is one of the pillars of NovaGroup, along with Novaland , Nova Service and 5 other members. In March 2022, the company completed the initial public offering (IPO) of 10.9 million shares at an offering price of VND 44,000/share. Thus, the listing price of Nova Consumer shares on UPCoM was nearly 14% lower than the time of IPO.
Shares with code NCG of Nova Consumer Group will be traded on UPCoM
According to the report, Nova Consumer currently has 256 shareholders, of which 3 major shareholders are Bao Khang Trading Joint Stock Company (65.61%), ANOVA Investment Joint Stock Company (13.72%) and a member of VinaCapital - Foremost Worldwide Limited (10.66%). Regarding operational information, Nova Consumer reported consolidated business results for the first 9 months of 2023 with net revenue reaching nearly VND 2,140.5 billion and a loss of more than VND 31 billion, while in the same period in 2022, it had a profit of VND 184.9 billion. Undistributed profit after tax up to the end of June 2023 was VND 1,132 billion. Previously, Nova Consumer announced its business results for the whole year of 2022 with net revenue of more than VND 4,880.3 billion and profit after tax of more than VND 273.5 billion. According to the 2023 business plan approved by shareholders, the company targets revenue of VND5,628.6 billion, an increase of 15.3%, but after-tax profit of more than VND16.8 billion, a decrease of 93.8% compared to 2022. The company's management said that due to fluctuations in pork prices, the company will minimize capital risks and not expand more sow and pork farms. The company will focus on maximizing the capacity of the currently rented farms to optimize fixed costs. However, the company will continue to maintain its current market share in the veterinary medicine segment; take advantage of the growth momentum from 2022 in the animal feed segment to gain more market share - which is the company's core business in the agricultural sector...
Comment (0)